Genetic Testing and Risk Factors for Alzheimer's Disease

The chapter explores the implications of genetic testing for the APOE4 gene in relation to Alzheimer's disease risk, discussing concerns about marketing treatments and the limitations of using APOE4 as a predictor. It also delves into the challenges of genetic testing, risk assessment for cardiovascular disease, and the potential impact on lifestyle changes based on test results. Additionally, the chapter highlights the relationship between high blood pressure and Alzheimer's disease, emphasizing the importance of long-term management for reducing dementia risk.